C07K 5/04
Containing only normal peptide links
Official title: containing only normal peptide links
C07K5/04 (Containing only normal peptide links) appears on 6,948 US grants and 6,180 published applications in this corpus.
Search patents in C07K- Granted patents
- 6,948
- Published applications
- 6,180
- Assignees
- 2,804
- Inventors
- 15,426
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 40 | 0 |
| 1977 | 46 | 0 |
| 1978 | 57 | 0 |
| 1979 | 41 | 0 |
| 1980 | 54 | 0 |
| 1981 | 66 | 0 |
| 1982 | 48 | 0 |
| 1983 | 45 | 0 |
| 1984 | 69 | 0 |
| 1985 | 74 | 0 |
| 1986 | 75 | 0 |
| 1987 | 117 | 0 |
| 1988 | 94 | 0 |
| 1989 | 107 | 0 |
| 1990 | 81 | 0 |
| 1991 | 81 | 0 |
| 1992 | 106 | 0 |
| 1993 | 114 | 0 |
| 1994 | 105 | 0 |
| 1995 | 143 | 0 |
| 1996 | 190 | 0 |
| 1997 | 245 | 0 |
| 1998 | 275 | 0 |
| 1999 | 201 | 0 |
| 2000 | 209 | 0 |
| 2001 | 198 | 36 |
| 2002 | 200 | 196 |
| 2003 | 185 | 287 |
| 2004 | 145 | 267 |
| 2005 | 134 | 280 |
| 2006 | 176 | 238 |
| 2007 | 152 | 229 |
| 2008 | 136 | 209 |
| 2009 | 158 | 287 |
| 2010 | 172 | 279 |
| 2011 | 158 | 259 |
| 2012 | 173 | 251 |
| 2013 | 212 | 281 |
| 2014 | 226 | 294 |
| 2015 | 224 | 297 |
| 2016 | 252 | 281 |
| 2017 | 193 | 244 |
| 2018 | 178 | 266 |
| 2019 | 161 | 230 |
| 2020 | 157 | 224 |
| 2021 | 145 | 240 |
| 2022 | 115 | 191 |
| 2023 | 112 | 226 |
| 2024 | 121 | 234 |
| 2025 | 118 | 206 |
| 2026 | 64 | 148 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Polypeptide compound and use thereof in treatment of enteritis29 Sep 2026US 12,747,267 B2Sichuan Gooddoctor Panxi Pharmaceutical Co., Ltd.
- Aqueous peptide programming of the vinylidene fluoride ferroelectric phase29 Sep 2026US 12,747,302 B2Northwestern University
- Tautomeric ligand enables biomimetic C—H hydroxylation with molecular oxygen22 Sep 2026US 12,741,937 B2The Scripps Research Institute
- Modulators of programmed death-ligand-122 Sep 2026US 12,741,965 B2Southern Research Institute
- Small molecule LIN28 inhibitors as anticancer agents22 Sep 2026US 12,741,987 B2Arumugavadivel Narendran
- Amino acid-derived ceramide, synthesis method therefor and use thereof1 Oct 2026US 2026/0297018 A1Shenzhen Dikeman Biotechnology Co., Ltd.
- Reversible surfactant and multifunctional drug delivery systems based thereon1 Oct 2026US 2026/0297127 A1Yissum Research Development Company of the Hebrew University of Jerusalem
- Universal abt compounds and uses thereof24 Sep 2026US 2026/0284204 A1Kleo Pharmaceuticals, Inc.
- Synthesized biologically active compounds and methods of making and using24 Sep 2026US 2026/0285903 A1Georgia State University Research Foundation, Inc.
- Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives17 Sep 2026US 2026/0273017 A1Ambrx, Inc.
Most cited
By later US patents
- Solid phase and combinatorial synthesis of benzodiazepine compounds on a solid support822US 5,288,514 AThe Regents of the University of California · 1994
- Peptide nucleic acids763US 5,539,082 A1996
- Lysosomal enzyme-cleavable antitumor drug conjugates653US 6,214,345 B1Bristol-Myers Squibb Company · 2001
- Peptide nucleic acids having enhanced binding affinity, sequence specificity and solubility543US 5,714,331 A1998
- Peptide nucleic acids having amino acid side chains515US 5,719,262 A1998